Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Review Article
Authors: Crestini, Alessioa | Santilli, Francescab; c | Martellucci, Stefanob | Carbone, Elenaa | Sorice, Maurizioc | Piscopo, Paolaa | Mattei, Vincenzob; c; *
Affiliations: [a] Department of Neuroscience, Istituto Superiore di Sanità, Rome, Italy | [b] Biomedicine and Advanced Technologies Rieti Center, “Sabina Universitas”, Rieti, Italy | [c] Department of Experimental Medicine, “Sapienza” University, Rome, Italy
Correspondence: [*] Correspondence to: Vincenzo Mattei, Biomedicine and Advanced Technologies Rieti Center, “Sabina Universitas”, Via Angelo Maria Ricci, 35/A – 02100, Rieti, Italy. Tel.: +39 07461739607; E-mail: v.mattei@sabinauniversitas.it.
Abstract: Specific protein misfolding and aggregation are mechanisms underlying various neurodegenerative diseases such as prion disease and Alzheimer’s disease (AD). The misfolded proteins are involved in prions, amyloid-β (Aβ), tau, and α-synuclein disorders; they share common structural, biological, and biochemical characteristics, as well as similar mechanisms of aggregation and self-propagation. Pathological features of AD include the appearance of plaques consisting of deposition of protein Aβ and neurofibrillary tangles formed by the hyperphosphorylated tau protein. Although it is not clear how protein aggregation leads to AD, we are learning that the cellular prion protein (PrPC) plays an important role in the pathogenesis of AD. Herein, we first examined the pathogenesis of prion and AD with a focus on the contribution of PrPC to the development of AD. We analyzed the mechanisms that lead to the formation of a high affinity bond between Aβ oligomers (AβOs) and PrPC. Also, we studied the role of PrPC as an AβO receptor that initiates an AβO-induced signal cascade involving mGluR5, Fyn, Pyk2, and eEF2K linking Aβ and tau pathologies, resulting in the death of neurons in the central nervous system. Finally, we have described how the PrPC-AβOs interaction can be used as a new potential therapeutic target for the treatment of PrPC-dependent AD.
Keywords: Alzheimer’s disease, Aβ oligomers, amyloid-β , amyloid-β protein precursor, neurodegenerative diseases, prion protein, prion protein refolding, prions, tau pathologies AβO-induced signal cascade
DOI: 10.3233/JAD-215171
Journal: Journal of Alzheimer's Disease, vol. 85, no. 2, pp. 503-518, 2022
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl